COVID-19 Community Levels Map Update, Jan. 27, 2023: The CDC has listed three Connecticut Counties—Litchfield, Middlesex and New Haven Counties—in the High/Orange category as part of its weekly COVID-19 Community Levels update. Fairfield, Hartford, New London, Tolland and Windham Counties are listed in the Medium/Yellow category.  Because all eight Connecticut counties are either in the High or Medium categories, the Connecticut Department of Public Health recommends that all residents consider wearing a mask in public indoor spaces. People who are at high risk for severe illness should consider additional measures to minimize their exposure to COVID-19 and other respiratory illnesses. Visit the CDC COVID-19 Community Levels Map for updates.

Please visit to request four free COVID-19 self-test kits from the Federal Government. Find a location that has a supply of COVID-19 therapeutics as part of the Test to Treat initiative here. The complete DPH COVID-19 toolbox is located at



(HARTFORD, CT) – Governor Dannel P. Malloy today announced the award of $9.8 million in stem cell research funds to twenty Connecticut–based researchers. The awards were given by the State of Connecticut Stem Cell Research Advisory Committee at its Tuesday grant review meeting in Farmington.


Seventy-nine stem cell funding applications were accepted for consideration in January 2011. The Connecticut Stem Cell Research Peer Review Committee reviewed these applications in accordance with National Institutes of Health guidelines and provided to the Advisory Committee its recommendations with respect to the scientific merits of each application.


“These awards signal Connecticut’s commitment to stem cell research and the life sciences sector,” said Governor Malloy. “Connecticut continues to conduct some of the finest stem cell research in the country, and these awardees further demonstrate Connecticut’s promise as a leader in bioscience.”


“This year’s awardees submitted a wide range of research projects ranging from basic stem cell research to a new disease directed category of grants which are closer to clinical application,” stated Advisory Committee Chairperson and Department of Public Health Commissioner Dr. Jewel Mullen. “I applaud the committee members for their commitment to this important effort.”


The following awards were made by the Connecticut Stem Cell Advisory Committee:


Identification of novel targets abnormally expressed in Prader-Willi Syndrome
University of Connecticut Health Center, Farmington
Kristin Martins-Taylor, Principal Investigator


Regulation of mRNA stability and translation in pluripotent and differentiated hES cells
University of Connecticut Health Center, Farmington
Alissa Resch, Principal Investigator


Single Cell Molecular Signatures for Hematopoietic Differentiation of Human Embryonic Stem Cells
Yale University, New Haven
Rong Fan, Principal Investigator


Role of Kalirin, a risk factor for schizophrenia, in human stem cells
University of Connecticut Health Center, Farmington
Xin-Ming Ma, Principal Investigator


The Role of Endocardial Cells in Human Down Syndrome-Related Heart Defects
Yale University, New Haven
Peter Amos, Principal Investigator


Role of the histone variant H2A.X in the establishment of the epigenetic landscape of human embryonic stem cells
Yale University, New Haven
Pascal Drane, Principal Investigator


MicroRNA mediated derivation of hemapoietic stem cells from human embryonic stem cells
Yale University, New Haven
Shangqin Guo, Principal Investigator


Investigation of gene expression adaptations to alcohol in iPS cell derived neural cultures from alcohol dependent control subjects
University of Connecticut Health Center, Farmington
Jonathan Covault, Principal Investigator


Identification and purification of smooth muscle cells from differentiating human embryonic stem cells for vascular tissue engineering
Yale University, New Haven
Sumati Sundaram, Principal Investigator


Cytoplasmic dsRNA response in human embryonic stem cells
University of Connecticut Health Center, Farmington
Gordon Carmichael, Principal Investigator


Devising a multidisciplinary approach for the treatment of articular cartilage damage using human ESC-derived chondrocytes
University of Connecticut Health Center, Farmington
Hicham Drissi, Principal Investigator


Phosphorylation Dynamics of Pluripotent Stem Cells
University of Connecticut Health Center, Farmington
David Han, Principal Investigator


Pulsatile tissue-engineered grafts for surgical correction of single ventricle cardiac anomalies
Yale University, New Haven
Yibing Qyang, Principal Investigator


Mechanisms of RNA Surveillance in Human Embryonic Stem Cells
Yale University, New Haven
Sandra Wolin, Principal Investigator


Differentiation of human iPSC and ES into functional neurons
Yale University, New Haven
Flora Vaccarino, Principal Investigator


Elucidating the development and disease of cortical motor neuron using human pluripotent stem cells
UConn Health Center, Farmington
Xue Jun Li, Principal Investigator


Angiogenesis of Embryonic Stem Cell Derived Hippocampus Transplants
Wesleyan University, Middletown
Laural Grabel, Principal Investigator


Development of a Potential Therapy for Osteoarthritic Cartilage Damage using hESC-derived Chondrogenic Cells
Chondrogenics, Inc., Farmington
Caroline Dealy, Principal Investigator


Continued Operation and Expansion of the Human Embryonic Stem Cell Core Facilities at the Yale Stem Cell Center
Yale University, New Haven
Haifan Lin, Principal Investigator


Stem Cell Approaches for Defining Patient-specific Predisposition to Idiosyncratic Drug-induced Liver Injury
University of Connecticut, Storrs
Urs Boelsterli, Principal Investigator




For Immediate Release: July 21, 2011

Contact: Bill Gerrish
Department of Public Health


Twitter: @GovMalloyOffice

Facebook: Office of Governor Dannel P. Malloy